[CAS NO. 1714146-59-4]  I-BRD9

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [1714146-59-4]

Store
Catalog
SLK-S7835
Brand
Selleck
CAS
1714146-59-4

DESCRIPTION [1714146-59-4]

Overview

MDL-
Molecular Weight497.55
Molecular FormulaC22H22F3N3O3S2
SMILESN=C(C(S1)=CC2=C1C(C3=CC=CC(C(F)(F)F)=C3)=CN(CC)C2=O)NC(CC4)CCS4(=O)=O

For research use only.

Storage

3 years,-20°C,powder
1 years,-80°C,in solvent

Shipping

Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

1 mg5 mg10 mg
1 mM2.0098 mL10.0492 mL20.0985 mL
5 mM0.4020 mL2.0098 mL4.0197 mL
10 mM0.2010 mL1.0049 mL2.0098 mL
50 mM0.0402 mL0.2010 mL0.4020 mL

Description

I-BRD9 (GSK602) is a potent and selective inhibitor with of 7.3, while it displayed a pIC50 of 5.3 against BRD4.

Targets

BRD9 [1]
(Cell-free assay)
BRD4 [1]
(Cell-free assay)
7.3(pIC50) 5.3(pIC50)

In vitro

I-BRD9 is identified through structure-based design, leading to greater than 700-fold selectivity over the BET family and 200-fold over the highly homologous bromodomain-containing protein 7 (BRD7). I-BRD9 is used to identify genes regulated by BRD9 in Kasumi-1 cells involved in oncology and immune response pathways and to the best of our knowledge, represents the first selective tool compound available to elucidate the cellular phenotype of BRD9 bromodomain inhibition.